{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-028854","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2024-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.555937+00:00","generated_at":"2026-05-31T17:04:07.890672+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Lucid Diagnostics shareholders approve increase in authorized shares, re-elect directors","bullets":["Stockholders re-elected Dr. Lishan Aklog, Debra White, and Dennis Matheis as Class C directors.","Approved amendment to increase authorized common stock from 200M to 300M shares.","Approved issuance of shares under Series B and B-1 Convertible Preferred Stock for Nasdaq Listing Rule 5635.","Ratified appointment of Marcum LLP as independent auditor for FY 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-028854","json":"https://secwatch.observer/filing/0001493152-24-028854.json","markdown":"https://secwatch.observer/filing/0001493152-24-028854.md","text":"https://secwatch.observer/filing/0001493152-24-028854.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000149315224028854/0001493152-24-028854-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000149315224028854/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T17:04:07.890672+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}